| Shared Decision-Making in the Treatment of Multiple Sclerosis: Results of a Cross-Sectional, Real-World Survey in Europe and the United States A Keenan, HH Le, K Gandhi, L Adedokun, E Jones, M Unsworth, J Pike, ... Patient preference and adherence, 137-149, 2024 | | 2024 |
| Patients’ Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment A Keenan, C Whichello, HH Le, DM Kern, GS Fernandez, V Turner, A Das, ... The Patient-Patient-Centered Outcomes Research, 1-12, 2024 | | 2024 |
| Exploring humanistic burden of fatigue in adults with multiple sclerosis: an analysis of US National Health and Wellness Survey data HH Le, J Ken-Opurum, A LaPrade, MC Maculaitis, JJ Sheehan BMC neurology 24 (1), 51, 2024 | | 2024 |
| Real-World Clinical Outcomes Among Triple-Class Exposed Multiple Myeloma Patients and Subgroups in the US Oncology Network RM Rifkin, JS Harper, HH Le, AZ Fu, SN Patel, X Zhang, IL Zackon Blood 142, 7362, 2023 | | 2023 |
| Clinician Perspectives on Treatment-Decision in Triple-Class-Exposed Relapsed Refractory Multiple Myeloma in the United States: A Delphi-Based Research Study R Fonseca, HH Le, N Lodowski, A DeBrosse, I Daniel, P Narvekar, ... Blood 142, 7400, 2023 | | 2023 |
| Real-World Treatment Patterns and Clinical Outcomes Among Triple-Class Exposed and B-Cell Maturation Antigen (BCMA) Exposed Multiple Myeloma Patients H Mian, JS Harper, HH Le, AZ Fu, SN Patel, X Zhang, R Fonseca Blood 142, 542, 2023 | 1 | 2023 |
| A Mixed Methods Study to Describe the Relationship between Burden of Illness, Social Needs, and Identity Experiences Among Patients with Multiple Myeloma N Neparidze, A Godara, D Lin, HH Le, K Fixler, L Shea, S Everson, ... Blood 142, 7353, 2023 | | 2023 |
| Brain volume loss in relapsing multiple sclerosis: Indirect treatment comparisons of available disease-modifying therapies R Zivadinov, AJ Keenan, HH Le, M Ait-Tihyaty, K Gandhi, ML Zierhut, ... | | 2023 |
| A retrospective claims analysis of fatigue in patients with multiple sclerosis on disease-modifying therapy TP Leist, M Cole, S Verma, A Keenan, HH Le Multiple Sclerosis and Related Disorders 78, 104917, 2023 | | 2023 |
| P-257 Real-world treatment patterns and clinical outcomes among patients with triple-class exposed (TCE) multiple myeloma (MM) R Fonseca, J Harper, H Le, A Fu, S Patel, B Wu, X Zhang Clinical Lymphoma Myeloma and Leukemia 23, S177-S178, 2023 | | 2023 |
| Treatment Convenience in Multiple Sclerosis: A Patient Preference Study A Keenan, C Whichello, M Quaife, DM Kern, G Fernandez, V Turner, ... 2023 Annual Meeting of the Consortium of Multiple Sclerosis Centers, 2023 | | 2023 |
| Severity and worsening of fatigue among individuals with multiple sclerosis A Salter, A Keenan, HH Le, K Gandhi, M Ait-Tihyaty, S Lancia, GR Cutter, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 9 (2 …, 2023 | 1 | 2023 |
| Assessing the impact of persistency for disease-modifying therapies in a German registry for multiple sclerosis S Braune, A Drewek, A Bergmann, A Keenan, K Gandhi, M Schuier, ... 38th Congress of the European Committee for Treatment and Research in …, 2022 | | 2022 |
| Assessment of brain volume loss by age in ponesimod relative to teriflunomide treated patients in the optimum phase 3 study T Sprenger, K Gandhi, HH Le, L Adedokun, I Turkoz, C Obando, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 547-547, 2022 | | 2022 |
| Assessing the benefits of disease modifying therapy in relapsing multiple sclerosis using the MAGNIMS score: a post-hoc analysis of OPTIMUM study of ponesimod by early relapse … K Gandhi, CG Pelligra, A Keenan, W Liao, M Ait-Tihyaty, S Guo, I Turkoz, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 877-878, 2022 | | 2022 |
| Is there an impact on early initiation of DMTs in patients with RRMS in the German registry? S Braune, A Drewek, A Bergmann, M Schuier, M Ait-Tihyaty, HH Le, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 894-895, 2022 | | 2022 |
| The association of MAGNIMS score with long-term disability progression in RMS HH Le, CG Pelligra, M Ait-Tihyaty, W Liao, A Keenan, M Kutch, S Guo, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 878-879, 2022 | | 2022 |
| Assessment of economic burden of fatigue in adults with multiple sclerosis: An analysis of US National Health and Wellness Survey data HH Le, J Ken-Opurum, A LaPrade, MC Maculaitis, JJ Sheehan Multiple Sclerosis and Related Disorders 65, 103971, 2022 | 8 | 2022 |
| Prognostic Value of the Magnims Score for Assessment of Disease Modifying Therapy in Patients with Relapsing Multiple Sclerosis Treated with Ponesimod A Keenan, K Gandhi, HH Le, I Turkoz, S Guo, W Liao, C Pelligra 2022 Annual Meeting of the Consortium of Multiple Sclerosis Centers, 2022 | 2 | 2022 |
| Estimated Prevalence of First-Dose Cardiac Observation in Patients Taking Ponesimod DM Kern, HH Le, M Ait-Tihyaty, A Keenan 2022 Annual Meeting of the Consortium of Multiple Sclerosis Centers, 2022 | | 2022 |
